← Open Payments lookup

EMILY WYATT: Open Payments

NPI 1912197674 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$762 in 36 payments from 12 companies in 2025. Trend: 2023 $1,053 · 2024 $883 · 2025 $762

Food & beverage: $762
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.9$195
Axsome Therapeutics, Inc.5$110
Otsuka America Pharmaceutical, Inc.4$89
Alkermes, Inc.3$68
ABBVIE INC.3$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$53
Janssen Pharmaceuticals, Inc2$43
Lundbeck LLC2$43
E.R. Squibb & Sons, L.L.C.2$37
Neurocrine BioSciences, Inc.1$28

Products named: FANAPT, REXULTI, Auvelity, ARISTADA, VRAYLAR, CAPLYTA, SPRAVATO, COBENFY.

Industry payments across LA — which companies pay providers there.